SIKE Inhibitors
Chemical inhibitors of SIKE can interfere with the protein's function through various mechanisms relating to its role in TBK1/IKKε-mediated signaling. Staurosporine, a broad-spectrum kinase inhibitor, can inhibit the kinase activity that SIKE is thought to regulate, thereby modulating the associated signaling pathways. Similarly, Wortmannin and LY294002, both specific inhibitors of phosphoinositide 3-kinases (PI3K), can indirectly inhibit SIKE's modulatory actions by reducing PI3K signaling, which is necessary for the full activation of the TBK1/IKKε complex. Rapamycin, which targets mTOR, a component of the PI3K/AKT pathway, can also indirectly affect SIKE by inhibiting downstream signaling components that may be upstream of the TBK1/IKKε complex.
Further indirect inhibition of SIKE is observed with the application of SB203580 and SP600125, which target p38 MAP kinase and c-Jun N-terminal kinase (JNK), respectively. Given that both p38 MAPK and JNK can influence TBK1 signaling, their inhibition can reduce the functional activity of SIKE. Additional compounds such as U0126 and PD98059, both MEK inhibitors, can suppress the MEK/ERK pathway, which is potentially linked to TBK1/IKKε signaling, thereby indirectly affecting SIKE's role. BAY 11-7082's inhibition of NF-κB activation and IKK-16's inhibition of IKK2 can also lead to a downregulation of TBK1 activity, and hence, SIKE activity. Lastly, Go6976 and KU-55933, which inhibit protein kinase C and ATM kinase respectively, can modify the signaling pathways that influence TBK1's function, thereby indirectly modulating the activity of SIKE within these pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. SIKE is involved in TBK1/IKKε-mediated signaling, and staurosporine can inhibit this by suppressing the kinase activity that SIKE might regulate. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a specific inhibitor of phosphoinositide 3-kinases. Since PI3K signaling can be linked to TBK1 activation, where SIKE acts as a regulator, inhibition of PI3K can indirectly inhibit SIKE's modulatory role in this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another inhibitor of phosphoinositide 3-kinases. By inhibiting PI3K, it can indirectly inhibit SIKE by reducing the activity within the TBK1/IKKε axis, which requires PI3K signaling for full activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is a downstream target of PI3K/AKT signaling. As SIKE is associated with TBK1/IKKε signaling, rapamycin can indirectly inhibit the functional role of SIKE by reducing the activity of mTOR, which is potentially upstream of TBK1/IKKε. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor. Since p38 MAPK can be involved in the regulation of TBK1, which interacts with SIKE, inhibition of p38 MAPK can lead to decreased TBK1 activity, thus indirectly inhibiting SIKE function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinase (JNK). JNK can be involved in the signaling pathways that regulate TBK1, which is associated with SIKE. Inhibiting JNK can decrease TBK1 activity, thus indirectly inhibiting SIKE. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are upstream of ERK1/2 in the MAPK pathway. By inhibiting MEK, this compound can reduce ERK activity, which may be linked to the regulation pathways involving TBK1 and indirectly inhibit SIKE. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that works similarly to U0126. It can indirectly inhibit SIKE by inhibiting the MEK/ERK pathway, which may affect TBK1 signaling. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an inhibitor of NF-κB activation. NF-κB pathway is potentially linked to TBK1 signaling, which is associated with SIKE. Inhibition of NF-κB may reduce TBK1 activity and thus indirectly inhibit SIKE. | ||||||
IKK 16 | 1186195-62-9 | sc-204009 sc-204009A | 10 mg 50 mg | $223.00 $942.00 | 2 | |
IKK-16 is an inhibitor of IKK2, which is part of the IκB kinase complex involved in NF-κB activation. As TBK1 is associated with IKK-related signaling, IKK-16 may indirectly inhibit SIKE by reducing TBK1 activity. | ||||||